Primary Site >> Biliary tract Cancer

Gene >> ERBB3

Journal: Virchows Arch. 2012 Nov;461(5):521-30.
Title: HER3 overexpression is a prognostic indicator of extrahepatic cholangiocarcinoma.
Author: Lee, Hee Jin|Chung, Joon-Yong|Hewitt, Stephen M|Yu, Eunsil|Hong, Seung-Mo
PMID: 23052372
Journal: Oncologist. 2014 Mar;19(3):235-42.
Title: New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.
Author: Ross, Jeffrey S|Wang, Kai|Gay, Laurie|Al-Rohil, Rami|Rand, Janne V|Jones, David M|Lee, Hwa J|Sheehan, Christine E|Otto, Geoff A|Palmer, Gary|Yelensky, Roman|Lipson, Doron|Morosini, Deborah|Hawryluk, Matthew|Catenacci, Daniel V T|Miller, Vincent A|Churi, C
PMID: 24563076
Journal: Oncol Rep. 2014 Aug;32(2):700-8.
Title: Characterization of EGFR family gene aberrations in cholangiocarcinoma.
Author: Yang, Xiaoqing|Wang, Weishan|Wang, Chunni|Wang, Lin|Yang, Muyi|Qi, Mei|Su, Hong|Sun, Xiubin|Liu, Zhiyan|Zhang, Juan|Qin, Xiaomin|Han, Bo
PMID: 24927194
Journal: Int J Clin Exp Pathol. 2014 Apr 15;7(5):1849-67. eCollection 2014.
Title: miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer.
Author: Letelier, Pablo|Garcia, Patricia|Leal, Pamela|Alvarez, Hector|Ili, Carmen|Lopez, Jaime|Castillo, Jonathan|Brebi, Priscilla|Roa, Juan Carlos
PMID: 24966896
Journal: Nat Genet. 2014 Aug;46(8):872-6.
Title: Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway.
Author: Li, Maolan|Zhang, Zhou|Li, Xiaoguang|Ye, Junyi|Wu, Xiangsong|Tan, Zhujun|Liu, Chang|Shen, Baiyong|Wang, Xu-An|Wu, Wenguang|Zhou, Daizhan|Zhang, Di|Wang, Ting|Liu, Bingya|Qu, Kai|Ding, Qichen|Weng, Hao|Ding, Qian|Mu, Jiasheng|Shu, Yijun|Bao, Runfa|Cao, Yan
PMID: 24997986
Journal: Expert Opin Biol Ther. 2016;16(2):243-53.
Title: Pertuzumab in gastrointestinal cancer.
Author: Oh, Do-Youn|Bang, Yung-Jue
PMID: 26619359
Journal: Cancer Metastasis Rev. 2017 Mar;36(1):141-157.
Title: HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?
Author: Galdy, Salvatore|Lamarca, Angela|McNamara, Mairead G|Hubner, Richard A|Cella, Chiara A|Fazio, Nicola|Valle, Juan W
PMID: 27981460
Journal: Pathol Res Pract. 2017 May;213(5):476-482.
Title: The ERK/MAPK pathway is overexpressed and activated in gallbladder cancer.
Author: Buchegger, Kurt|Silva, Ramon|Lopez, Jaime|Ili, Carmen|Araya, Juan Carlos|Leal, Pamela|Brebi, Priscilla|Riquelme, Ismael|Roa, Juan Carlos
PMID: 28285962
Journal: Hepatology. 2017 Jul 3.
Title: Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology.
Author: Pellat, Anna|Vaquero, Javier|Fouassier, Laura
PMID: 28671339
Journal: Gut. 2018 Jun 28. pii: gutjnl-2018-316039.
Title: Genomic ERBB2/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis.
Author: Li, Maolan|Liu, Fatao|Zhang, Fei|Zhou, Weiping|Jiang, Xiaoqing|Yang, Yuan|Qu, Kai|Wang, Yueqi|Ma, Qiang|Wang, Ting|Bai, Lu|Wang, Zheng|Song, Xiaoling|Zhu, Yidi|Yuan, Ruiyan|Gao, Yuan|Liu, Yongchen|Jin, Yunpeng|Li, Huaifeng|Xiang, Shanshan|Ye, Yuanyuan|Zha
PMID: 29954840
Journal: PLoS One. 2018 Oct 18;13(10):e0206007.
Title: The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers.
Author: Lamarca, Angela|Galdy, Salvatore|Barriuso, Jorge|Moghadam, Sharzad|Beckett, Elizabeth|Rogan, Jane|Backen, Alison|Billington, Catherine|McNamara, Mairead G|Hubner, Richard A|Cramer, Angela|Valle, Juan W
PMID: 30335866